2.32
Ensysce Biosciences Inc stock is traded at $2.32, with a volume of 316.52K.
It is up +3.11% in the last 24 hours and up +9.95% over the past month.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
See More
Previous Close:
$2.25
Open:
$2.25
24h Volume:
316.52K
Relative Volume:
0.91
Market Cap:
$6.89M
Revenue:
-
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.7708
EPS:
-3.01
Net Cash Flow:
$-9.78M
1W Performance:
-4.53%
1M Performance:
+9.95%
6M Performance:
+14.29%
1Y Performance:
-13.01%
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Name
Ensysce Biosciences Inc
Sector
Industry
Phone
(858) 263-4196
Address
7946 IVANHOE AVENUE, LA JOLLA
Compare ENSC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ENSC
Ensysce Biosciences Inc
|
2.32 | 6.68M | 0 | -11.28M | -9.78M | -3.01 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ensysce Biosciences Inc Stock (ENSC) Latest News
Will Ensysce Biosciences Inc. stock see PE expansionJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-10-13 07:07:18 - newser.com
Detecting price anomalies in Ensysce Biosciences Inc. with AI2025 Market Outlook & Momentum Based Trading Signals - newser.com
Will Ensysce Biosciences Inc. bounce back from current supportQuarterly Trade Summary & Community Consensus Trade Signals - newser.com
How sentiment analysis helps forecast Ensysce Biosciences Inc.Earnings Miss & Stock Portfolio Risk Management - newser.com
Building trade automation scripts for Ensysce Biosciences Inc.2025 Trading Volume Trends & Real-Time Volume Spike Alerts - newser.com
Will Ensysce Biosciences Inc. continue its uptrendWeekly Trend Report & Daily Chart Pattern Signals - newser.com
Historical volatility pattern of Ensysce Biosciences Inc. visualizedMarket Risk Summary & Capital Efficient Trading Techniques - newser.com
Will a bounce in Ensysce Biosciences Inc. offer an exitWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
PAINWeek 2025 highlights: Ensysce Biosciences shares symposium video on TAAP™ & MPAR® - Stock Titan
Will Ensysce Biosciences Inc. stock continue upward momentumLayoff News & Verified Short-Term Plans - newser.com
Statistical indicators supporting Ensysce Biosciences Inc.’s strength2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
Weiss Ratings Reaffirms “Sell (E+)” Rating for Ensysce Biosciences (NASDAQ:ENSC) - Defense World
Ensysce Biosciences Inc Stock Analysis and ForecastReal-Time Stock Alerts & Low Cost Trading Plans - earlytimes.in
Applying Elliott Wave Theory to Ensysce Biosciences Inc.Portfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Can trapped investors hope for a rebound in Ensysce Biosciences Inc.Quarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Ranking Ensysce Biosciences Inc. among high performing stocks via tools - newser.com
Full technical analysis of Ensysce Biosciences Inc. stock2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Custom watchlist performance reports with Ensysce Biosciences Inc.Weekly Trade Review & Trade Opportunity Analysis Reports - newser.com
News impact scoring models applied to Ensysce Biosciences Inc.Short Setup & Technical Analysis for Trade Confirmation - newser.com
Evaluating Ensysce Biosciences Inc. with trendline analysisDip Buying & Free Reliable Trade Execution Plans - newser.com
Is Ensysce Biosciences Inc. stock a buy on dips2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
Ensysce Biosciences (NASDAQ:ENSC) Trading Up 1.3% – Should You Buy? - Defense World
Ensysce Biosciences Inc Stock (ENSC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):